started · updated
Greece and Cyprus announce seasonal respiratory virus vaccination plans
Health authorities in Greece and Cyprus have released vaccination plans to combat seasonal respiratory viruses, including influenza, SARS-CoV-2, and Respiratory Syncytial Virus (RSV).
In Greece, the influenza vaccine is recommended for citizens aged 60 and older, infants and children from 6 months to 5 years, individuals with chronic conditions such as asthma, diabetes, or heart disease, pregnant women, and healthcare workers. Conventional vaccines can be obtained directly from pharmacies with a national ID, while enhanced vaccines for those 65 and older require an electronic prescription. Experts note that the influenza vaccine can be safely administered on the same day as a COVID-19 vaccine in a different anatomical location.
In Cyprus, the Ministry of Health is providing free vaccines and emphasizes that timely vaccination during autumn and winter is the most effective strategy for public health. The vaccination campaign is scheduled to begin in the first ten days of October 2026, starting with the Efluelda vaccine for individuals over 60. The Vaxigrip TIV vaccine, available for those over 6 months old, will follow in a subsequent announcement. International pharmacovigilance systems have not recorded serious systemic side effects from the influenza vaccine.